Kidswell Bio Corporation

4584・Growth Market・Pharmaceuticals

Official website

Kidswell Bio Corporation

4584・Growth Market・Pharmaceuticals

Official website

Kidswell Bio Corporation4584

Reference Indicators

Market Cap

74¥100M

P/E (Forecast)

—

P/B

4.6x

Dividend Yield (Forecast)

0.00%

ROE

-27.3%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	1,569	2,776	2,431	5,082	6,589
Cost of Sales	550	1,250	1,391	3,441	4,842
Gross Profit	1,018	1,525	1,039	1,640	1,747
SG&A Expenses	1,937	2,076	2,374	1,612	1,885
Operating Income	-919	-550	-1,335	27	-138
Non-operating Income	2	3	6	26	46
Non-operating Expenses	36	77	60	49	282
Ordinary Income	-952	-624	-1,389	5	-374
Extraordinary Income	418	—	4	108	10
Extraordinary Losses	—	31	35	40	38
Pre-tax Income	-533	-656	-1,420	72	-402
Income Taxes	1	1	1	94	11
Net Income	-535	-657	-1,422	-21	-413
EBITDA	-916	-549	-1,334	28	-138
Gross Margin	64.9%	55.0%	42.8%	32.3%	26.5%
Operating Margin	-58.6%	-19.8%	-54.9%	0.5%	-2.1%
ROA	-15.3%	-16.9%	-28.0%	-0.3%	-6.8%
ROE	-34.9%	-63.4%	-212.3%	-1.7%	-27.3%